Skip to main content

Table 3 Blood transfusion and hemostatic therapy during the first 24 hours after hospital admission

From: Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients

  NCT group FC group FC-PCC group P-value
RBC, U 0 (0 to 2) 3 (0 to 5) 8 (6 to 10.5) <0.0001
FFP, U 0 (0 to 0) 0 (0 to 0) 0 (0 to 0) ns
Platelet concentrate, U 0 (0 to 0) 0 (0 to 0) 0 (0 to 1) <0.0001
Fibrinogen concentrate, g 0 (0 to 0) 3 (3 to 5) 8 (5 to 11) 0.0002
PCC, IU 0 (0 to 0) 0 (0 to 0) 2,400 (1,650 to 2,500) nc
  1. RBC, red blood cells; FFP, fresh frozen plasma; nc, not calculated; ns, not significant; PCC, prothrombin complex concentrate; NCT group, no coagulation therapy; FC group, fibrinogen concentrate only; FC-PCC group, prothrombin complex concentrate and fibrinogen concentrate. Data are presented as median (interquartile range). P-values are derived from the Kruskal-Wallis test; significance level P <0.05.